A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost constraints in the region's publicly funded health care systems continue to hinder adoption of premium-priced DCBs and DES and limit the pace of revenue expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Latin America across a 10-year period.


A meta-analysis was published in 2018 that showed an increased risk of death associated with paclitaxel-coated balloons and stents after 2 years.

What effect did data highlighting safety concerns with paclitaxel-coated devices have on the DCB and DES market?

How were other PTA balloon catheter markets affected by turmoil in the DCB market?

How has this study impacted physicians' perception of these products?

Competitors are developing DES and DCBs that do not use paclitaxel.

What companies are developing these products?

What impact will the approval of such products have on use of existing devices?

Endovascular treatment of PVD is increasing in Latin America.

Which country has the highest penetration of endovascular procedures?
What factors influence the selection of PV stents or PTA balloons for endovascular procedures among the Latin American countries covered?
Which country will see the highest procedural and market revenue growth?

Most segments in the Latin American PV device market continue to be dominated by large international manufacturers.

Which companies are the leading competitors in each of the PV device segments?

What competitive strategies can firms use to maintain and/or improve their competitive positions going forward?

Table of contents

  • Latin America
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Peripheral Vascular Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication (Procedures Only)
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Clinical Data
        • Market Appeal
        • Mergers, Acquisitions, and Partnerships
        • Distribution and Sales Network
        • Competition from Alternatives
        • Physician Training and Marketing
      • Market Developments
    • Peripheral Vascular Stent Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication
        • By Product Type
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
    • PTA Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication
        • By Product Type
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Clinical Data
        • Market Appeal
    • Embolic Protection Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Peripheral Vascular Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Guidewires
        • Diagnostic Catheters
        • Sheaths
        • Guiding Catheters
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Surgical Graft Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication
        • By Material
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies

Author(s): Pankhil Gandhi, PharmD

Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.


Related Reports

Peripheral Vascular Devices | Medtech 360 | Market Insights | Canada

The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product l...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for PV devices will grow modestly through 2028, fueled by the growing PAD&nbs...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Japan

The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | United States

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for sign...

View Details